AI药物设计

Search documents
低空经济缺人?广东这场会上,人大代表建议开设“微专业”
Nan Fang Du Shi Bao· 2025-09-15 12:05
Group 1 - Guangdong has prioritized the cultivation of high-quality talent to support the construction of a modern industrial system, with over 1 million college graduates attracted to work and start businesses in the region by July 2025 [1] - A special meeting was held on September 15 to discuss the acceleration of modern industrial system construction, focusing on high-quality talent cultivation [1] - National representatives provided suggestions on talent cultivation, innovation, and mobility to enhance the talent support for Guangdong's modern industrial system [1] Group 2 - The establishment of "micro-specialties" is recommended to empower emerging industries, particularly in the low-altitude economy, with a focus on interdisciplinary talent [2] - Suggestions include creating a "Low Altitude Regulations and Ethics" interdisciplinary course and a provincial low-altitude economic talent development fund [2] - Emphasis on deepening industry-education integration and practical training to enhance the capabilities of graduates in relevant fields [2] Group 3 - Recommendations for a "Biomedicine Future Industry Talent Training Program" to encourage multi-position training and establish a cross-school "Biomedicine + X" micro-specialty [3] - The proposal to create a talent "reverse flying ground" to separate innovation and application, facilitating targeted talent development [3] - Suggestions to enhance talent retention through regional honor systems and professional communities to reduce talent loss [3] Group 4 - The importance of breaking down barriers to talent mobility between institutions, enterprises, and research platforms is emphasized [4] - Encouragement for innovative enterprises to engage research personnel in applied research to promote two-way talent flow [5] - Recommendations for reforming talent evaluation mechanisms to grant enterprises greater autonomy in talent assessment [5]
【新华解读】医药工业以数智化破解研发、生产等环节堵点
Zhong Guo Jin Rong Xin Xi Wang· 2025-04-24 13:58
Core Viewpoint - The "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" aims to enhance the efficiency, quality, and innovation capabilities of the pharmaceutical industry through digital transformation and the application of technologies like artificial intelligence [1][2]. Group 1: Transformation Goals - By 2027, the plan targets breakthroughs in key technologies, the establishment of over 30 technical standards, and the development of more than 100 high-performance products in smart pharmaceutical equipment and software [2]. - The plan aims for full coverage of digital transformation among large-scale pharmaceutical enterprises by 2030 [2]. Group 2: Key Actions - The plan outlines four main action areas: empowering with digital technology, promoting digital transformation, building a supportive service system, and enhancing regulatory capabilities [3][4][5][6]. - Specific tasks include developing exemplary application scenarios, fostering leading enterprises, and establishing innovation platforms [2][6]. Group 3: Industry Impact - The digital transformation is expected to accelerate the entire pharmaceutical supply chain, improving collaboration and operational efficiency from raw material suppliers to healthcare institutions [7]. - AI-driven platforms are anticipated to significantly reduce drug development cycles and costs, facilitating faster market entry for new drugs [8][10]. Group 4: Traditional Medicine Modernization - The digital transformation will also support the modernization and internationalization of traditional Chinese medicine, enhancing its quality and consistency through automated production processes [8][10]. - AI technologies are being utilized to optimize traditional medicine formulations and predict new indications, thereby streamlining the research and development process [8][10].